Displaying items by tag: school of medicine

A monoclonal antibody is being developed by Aridis Pharmaceuticals as an inhaled, self-administered treatment for non-hospitalized patients who are suffering from mild to moderate COVID-19.
The COVID-19 pandemic has impacted many aspects of normal life, but infectious diseases experts explain ways to enjoy the semester while minimizing health risks.
New recommendations for treatment and prevention of HIV infection in adults will help guide physicians and patients in HIV therapies and treatment regimens.
Benjamin Larimer, Ph.D., has received a $1.5 million award to conduct research on a PET-based diagnostic tool that could identify patients who will respond to immunotherapy.
Integration of the telehealth platform in a multiphase optimization strategy evaluation will allow researchers to develop behavioral health approaches that are more realistic and tailored to the individual’s goals and health needs.
UAB’s new cystic kidney disease core center will spearhead a multidisciplinary approach to finding treatments for this devastating disease
Project ECHO links medical professionals with an expert in a particular field in an interactive video format to boost learning and, ultimately, patient care.
A rare brain tumor caused facial paralysis for a local award-winning theater actress, but thanks to UAB doctors she is ready to get back on stage.
Precision disease modeling involves creation of patient-specific disease models that mimic the molecular character of a condition present in a patient, enabling more precise diagnoses and treatments.
The virus responsible for COVID-19 seems to have an affinity for the heart, leading to concerns for an increase in heart issues among young athletes.
This avenue of basic research will aid understanding of neurodevelopmental disorders in humans.
Physicians say it is crucial for trainees to have role models and mentors who have shared experiences.
The unit is designed to provide nursing home residents with the skilled care they need while recovering from COVID-19 in a safe environment.
The exosomes were secreted by cardiac cells derived from human induced pluripotent stem cells. These non-living exosomes may be an easier form of regenerative treatment than living cells.
Page 57 of 170